Utilize este identificador para referenciar este registo:
https://hdl.handle.net/10216/149470Registo completo
| Campo DC | Valor | Idioma |
|---|---|---|
| dc.creator | Bhering, M | - |
| dc.creator | Sarubbi Junior, V | - |
| dc.creator | Kritski, A | - |
| dc.creator | Souza, FBA | - |
| dc.creator | Duarte, R | - |
| dc.date.accessioned | 2023-05-23T14:23:13Z | - |
| dc.date.available | 2023-05-23T14:23:13Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.issn | 2504-3137 | - |
| dc.identifier.issn | 2504-3145 | - |
| dc.identifier.uri | https://hdl.handle.net/10216/149470 | - |
| dc.description.abstract | Introduction: The increase in drug-resistant tuberculosis (TB) threatens global progress in eliminating TB, and constitutes a major challenge for patients, health-care workers and health services. Treatment for multidrug-resistant TB (MDR-TB) can last almost 2 years, and is more expensive, more toxic, and less effective than treating TB caused by drug-sensitive bacilli. This study aims to analyze patients’ narratives about the challenges they face during MDR-TB treatment and identify the support factors that help patients being treated in the most populous district of Portugal. Methods: Semi-structured interviews were conducted with patients being treated for MDR-TB. The interviews were coded using thematic analysis. They were audio-recorded, transcribed, and transported into NVivo v12 for data management and coding. Results: Depression, social discrimination, and the side effects of drugs are the main challenges faced by patients with MDR-TB. A good relationship of the patients with the health team, emotional support, and supervised treatment stand out as the factors that generate better adherence and treatment success. Conclusion: In addition to modern diagnostic techniques and new treatments, MDR-TB can be fought by focusing on the care and needs of patients. We suggest that the Lisbon Tuberculosis Program adopts the following measures: build the health-care team’s capacity to identify symptoms of depression early, increase public awareness of the disease, expand the multidisciplinary team, and expand the options for individualized social support for patients. | - |
| dc.language.iso | eng | - |
| dc.publisher | Karger Publishers | - |
| dc.relation.ispartof | Port J Public Health 2020;38:62–70 | - |
| dc.rights | openAccess | - |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | - |
| dc.subject | Tuberculose | - |
| dc.subject | Tuberculose multirresistente | - |
| dc.subject | Investigação qualitativa | - |
| dc.subject | Estigma social | - |
| dc.subject | Avaliação de necessidades | - |
| dc.subject | Relação profissional-doente | - |
| dc.subject | Assistência ao paciente | - |
| dc.subject | Apoio social | - |
| dc.title | Multidrug-Resistant Tuberculosis in Portugal: Patients' Perception of the Challenges Faced during Treatment | - |
| dc.type | Artigo em Revista Científica Internacional | - |
| dc.contributor.uporto | Instituto de Saúde Pública da Universidade do Porto | - |
| dc.identifier.doi | 10.1159/000511198 | - |
| dc.relation.publisherversion | https://www.karger.com/Article/FullText/511198 | - |
| Aparece nas coleções: | ISPUP - Artigo em Revista Científica Internacional | |
Ficheiros deste registo:
| Ficheiro | Descrição | Tamanho | Formato | |
|---|---|---|---|---|
| bhering-pjph-2021.pdf | 263.9 kB | Adobe PDF | ![]() Ver/Abrir |
Este registo está protegido por Licença Creative Commons
